Key statistics
On Thursday, CSL Ltd (CMXHF:QXE) closed at 172.35, 4.30% above its 52-week low of 165.25, set on Nov 21, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 172.35 |
---|---|
High | 172.35 |
Low | 172.35 |
Bid | -- |
Offer | -- |
Previous close | 170.45 |
Average volume | 582.38 |
---|---|
Shares outstanding | 484.21m |
Free float | 483.71m |
P/E (TTM) | 32.68 |
Market cap | 132.54bn AUD |
EPS (TTM) | 8.37 AUD |
Annual div (ADY) | 2.64 USD |
---|---|
Annual div yield (ADY) | 1.53% |
Div ex-date | Sep 10 2024 |
Div pay-date | Oct 02 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024 17:46 GMT.
More ▼
Press releases
- Pharmanovia Acquires Exclusive Rights to Treatment for Parkinson’s Disease
- Self-Amplifying mRNA COVID-19 Vaccine Demonstrates Superior Immune Response Compared with mRNA Vaccine at 12 Months Post-Vaccination
- Japan’s Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma